Child pages
  • Annotations for Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma (CALGB50303-Tumor-Annotations)
  Name Size Creator Creation Date Labels Comment  
File CALGB50303_SourceImages_SEGSandSeedpoints-manifest-03-30-2023.tcia 32 kB Brenda Fevrier-Sullivan Mar 30, 2023 11:31
  • No labels
   
File CALGB50303_SourceImages_NegativeAssessments-manifest-03-30-2023.tcia 10 kB Brenda Fevrier-Sullivan Mar 30, 2023 11:25
  • No labels
   
File CALGB50303_Tumor-Annotations-manifest_03-30-2023.tcia 155 kB Brenda Fevrier-Sullivan Mar 30, 2023 11:25
  • No labels
   
Microsoft Powerpoint Presentation 3D Slicer user guidelines .pptx 4.08 MB Brenda Fevrier-Sullivan Mar 30, 2023 11:14
  • No labels
 
File Metadata_Report_CALGB50303_02272023.csv 702 kB Brenda Fevrier-Sullivan Mar 30, 2023 11:08
  • No labels
   
Download All